NEW YORK, November 22, 2011 /PRNewswire/ --
According to a new report published by Transparency Market Research (http://www.transparencymarketresearch.com ) " Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016) "Global Coronary Stents market is estimated to be USD 6,013million in 2011 and expected to reach USD 8,292million in 2016 at a CAGR of 6.6% over the period 2010 to 2016. The Drug Eluting Stents (DES) segment is the leading market contributor with a share of around 55% - 60% in 2010.
Browse full report at http://www.transparencymarketresearch.com/coronary-stents-market.html 
With the high prevalence of cardiovascular diseases, the global coronary stent market  is gaining every year experiencing a 6.6% CAGR growth. Also, owing the growth in demand for minimally invasive procedures, these stents, especially drug eluting stents, are finding rapid increase in their market penetration of more than 60% approximately.
The drug eluting stents (DES)  segment contributed 55%-60% of the global coronary stent market in 2010. The global DES segment is expected to reach USD 5.3 billion in 2016 after growing at a CAGR of 9.54% from 2011 to 2016.The biggest factor in the growth of this market is found in the aging populations in developed countries. Segmented by geographic regions, the market for Drug Eluting Stents (DES) is growing at 9.0% in the United States, at 3.1% in Europe, at 10% in Asia-Pacific and 3.1% in the rest of the world. At present, the stronge